Imagin Medical Inc.
Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The company's initial target is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and most costly cancer to treat due to greater than 50% recurrence rate.
Imagin Medical is developing the i/Blue™ Imaging System to significantly improve surgeons’ ability to visualize cancerous cells and enable more accurate bladder cancer resection. Using innovative optic and light sensor technology, the i/Blue System combines the advantages of white and blue light cystoscopy with fluorescing contrast agents to simultaneously display white and blue light images on the surgical monitor, side-by-side, in real-time. Based on functional prototype demonstrations, leading urologists have indicated that this feature could make bladder cancer detection and removal more accurate and efficient, potentially reducing recurrence rates.
Imagin Medical Inc. (IME)
Le 26 octobre/October 2020
Imagin Medical Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common shares for every twenty (20) pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 8,917,013 common shares
The name and symbol will not change.